[CIS-PAGID] NZ infant with PJP

Jan Sinclair (ADHB) JanS at adhb.govt.nz
Wed Apr 27 19:25:51 EDT 2011


Dear PAGID members

Would appreciate any thoughts on a male infant, now 6 months old. New Zealand born, South East Asian parents, non consanguineous. 1st child to this couple. Early oral candida, responding to treatment but recurring each time treatment stopped.

He presented at 3 months of age with:
* Pneumocystis pneumonia, problematic course needing prolonged intensive care stay, complicated by biopsy proven pulmonary alveolar proteinosis (managed with repeated pulmonary lavage), now well from a respiratory point of view.
* Failure to thrive and chronic diarrhoea. Negative for all GI pathogens (bacterial and viral including PCR), upper and lower scope with normal pathology on 2 occasions. Diarrhoea improved with TPN and now gaining weight but unable to transition back to oral feeds.

Investigations:
* Thymus present on first CXR
* Normal / raised lymphocyte count (most often 6-12 x 109/l)
* No rash, no hepatosplenomegaly, and no adenopathy
* Mild metaphyseal dysplasia, skeletal survey otherwise no abnormality
* Phenotype (repeated over time and essentially unchanged)
CD4 49 % Absolute CD4 6138 X10E6/L
CD8 22 % Absolute CD8 2755 X10E6/L
CD4:CD8 ratio 2.2
CD3 70 % Absolute CD3 8823 X10E6/L
CD19 27 % Absolute CD19 3451 X10E6/L
CD56 2 % Absolute CD56 297 X10E6/L
* TREC normal
* Vb repertoire polyclonal
* No maternal engraftment
* Immunoglobulins presentation Feb Mar Now
IgG 1.7 IVIG IVIG IVIG
IgA 0.29 0.48 <0.07 0.11
IgM 0.06 1.8 0.17 0.12
* CD40L normal

Proliferation:
At presentation PATIENT CONTROL
cpm SI cpm SI
Background 122 26
PHA 1409 11.5 27539 1059.2
CON A 1747 14.3 7265 279.4
CD3 Response 67 0.5 4696 180.6

On repeat testing these have improved markedly, most recently:
PATIENT SI Control SI
Background 432 70
PHA 138930 321 111031 1586
T3 16128 37 47781 683
PMA 3931 9 9100 130
Ionomycin 320 1 238 3
PMA + Ionomycin 47755 110 229807 3283


The initial thought was that he may have a T cell activation defect. Calcium flux studies were kindly undertaken by Prof Stefan Feske in New York, which were normal, excluding ORAI1 or STIM1 as the underlying defect.

Early in his course the plan was to consider HSCT, with good cord matches available. We are currently not hurrying in that direction, with normalisation of his proliferation, a slew of other normal investigations, and no diagnosis. However he is still TPN dependent and his immunoglobulin results suggest loss of IgA and M production.

Any thoughts (underlying defect / other investigations / treatment options) would be welcome.

Dr Jan Sinclair
Paediatric Immunology
Starship Children's Hospital
Auckland, New Zealand
Ph (64 9) 307 8900 extension 6429
Fax (64 9) 307 8977 (internal 5977)
Mobile 021 365 445


#####################################################################################
Scanned by MailMarshal - Marshal8e6's comprehensive email content security solution.
Download a free evaluation of MailMarshal at www.marshal.com
#####################################################################################
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://seven.pairlist.net/mailman/private/pagid/attachments/20110428/e133b9d2/attachment-0001.htm>


More information about the PAGID mailing list